Solid Biosciences Inc. — Director's Dealing 2021

Jan 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2021-01-25

Reporting Person: Morris Carl Ashley (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-25	Employee Stock Option (Right to Buy)	$6.80	A	175000	Acquired	2031-01-25	Common Stock (175000)	Direct

Footnotes

F1: This option was granted on January 25, 2021 and vests in four equal annual installments on the anniversary of the grant date.